Optimal Timing of Influenza Vaccine Production Under Yield-Improving and Knowledge Acquisition Strategies

42 Pages Posted: 21 Jun 2019

See all articles by Alexandar Angelus

Alexandar Angelus

Texas A&M University - Department of Information & Operations Management

Özalp Özer

Jindal School of Management - The University of Texas at Dallas

Date Written: June 16, 2019

Abstract

In this paper, we consider a decision faced each year by an influenza vaccine manufacturer: when to optimally start large-scale production of the influenza vaccine after receiving viral candidate strains from the FDA. Prior to launching production, the manufacturer can take the time to stochastically increase the uncertain yield of the influenza vaccine by learning through experimentation how to improve virus growth conditions, thus forsaking immediate profits but raising future ones. After starting large-scale production, and receiving revenues from the sale of the vaccine, the manufacturer can continue to stochastically improve the vaccine yield by acquiring knowledge from real-time production data. We formulate and solve a multi-period, sequential-decision model to determine the optimal vaccine production timing while incorporating the dynamic evolution of vaccine yield uncertainty under those two knowledge acquisition strategies available to the vaccine manufacturer. We establish the structure of the optimal stopping policy for the timing of influenza vaccine production even though, due to the multifaceted impact of yield uncertainty on vaccine production economics, the resulting objective function is generally neither concave nor convex nor monotonic. We show that the structure of the optimal stopping policy depends in a fundamental way on the relative stochastic rates of the two knowledge acquisition strategies. We also analyze the implications of those strategies for bringing the influenza vaccine to the market earlier in the season. Using our results, we quantify the benefits from knowledge acquisition for increasing profits for the vaccine manufacturer and bringing the influenza vaccine to the market sooner. We discuss the resulting managerial implications.

Keywords: dynamic programming, optimal stopping, influenza vaccine, yield uncertainty

Suggested Citation

Angelus, Alexandar and Özer, Özalp, Optimal Timing of Influenza Vaccine Production Under Yield-Improving and Knowledge Acquisition Strategies (June 16, 2019). Available at SSRN: https://ssrn.com/abstract=3402142 or http://dx.doi.org/10.2139/ssrn.3402142

Alexandar Angelus (Contact Author)

Texas A&M University - Department of Information & Operations Management ( email )

430 Wehner
College Station, TX 77843-4218
United States

Özalp Özer

Jindal School of Management - The University of Texas at Dallas ( email )

Jindal School of Management
800 W. Campbell Road
Richardson, TX 75080
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
11
Abstract Views
126
PlumX Metrics